ECONOMICS OF INTRAVENOUS FERRIC CARBOXYMALTOSE FOR TREATMENT OF IRON DEFICIENT ANAEMIA IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE: A PILOT STUDY IN ITALY

被引：0
|
作者：
Minutolo, Roberto [2 ]
Liberti, Maria Elena [2 ]
Berto, Patrizia [1 ]
机构：
[1] Analyt Laser, Value & Access Consulting, Milan, Italy
[2] Univ Campania, Div Nephrol, Dept Sci Med, Chirurg,Neurol,Metab Invecchiamento, Naples, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP335
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients
    Qunibi, Wajeh Y.
    Martinez, Carlos
    Smith, Mark
    Benjamin, Joseph
    Mangione, Antoinette
    Roger, Simon D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (05) : 1599 - 1607
  • [2] RENAL FUNCTION IN PATIENTS WITH NON-DIALYSIS KIDNEY DISEASE TREATED WITH FERRIC CARBOXYMALTOSE
    Roldao, Marisa
    Duarte, Rui
    Escoli, Rachele
    Goncalves, Hernani
    Lobos, Ana Vila
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I381 - I381
  • [3] INTRAVENOUS FERRIC CARBOXYMALTOSE VS ORAL IRON IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY: RESULTS OF THE RANDOMISED FIND-CKD STUDY
    Macdougall, I. D.
    Bock, A.
    Carrera, F.
    Eckardt, K-U
    Gaillard, C.
    Van Wyck, D.
    Roubert, B.
    Nolen, J.
    Roger, S. D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 21 - 21
  • [4] Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial
    Iain C. Macdougall
    Andreas H. Bock
    Fernando Carrera
    Kai-Uwe Eckardt
    Carlo Gaillard
    David Van Wyck
    Yvonne Meier
    Sylvain Larroque
    Simon D. Roger
    [J]. BMC Nephrology, 18
  • [5] Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial
    Macdougall, Iain C.
    Bock, Andreas H.
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Gaillard, Carlo
    Van Wyck, David
    Meier, Yvonne
    Larroque, Sylvain
    Roger, Simon D.
    [J]. BMC NEPHROLOGY, 2017, 18
  • [6] THE TREATMENT OF IRON DEFICIENCY/ANAEMIA IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE IN GERMANY - A CLAIMS DATABASE ANALYSIS
    Haas, J. S.
    Borchert, K.
    Krinke, K.
    Gavata-Steiger, S.
    Greiner, W.
    Braun, S.
    [J]. VALUE IN HEALTH, 2018, 21 : S476 - S477
  • [7] Switching Patients with Non-Dialysis Chronic Kidney Disease from Oral Iron to Intravenous Ferric Carboxymaltose: Effects on Erythropoiesis-Stimulating Agent Requirements, Costs, Hemoglobin and Iron Status
    Toblli, Jorge Eduardo
    Di Gennaro, Federico
    [J]. PLOS ONE, 2015, 10 (04):
  • [8] THE DIFFERENTIAL EFFECT OF THIRD-GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON CARDIOVASCULAR PARAMETERS IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANAEMIA
    Kassianides, Xenophon
    Bhandari, Sunil
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I385 - I385
  • [9] THE DIFFERENTIAL EFFECT OF THIRD GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON PATIENT RELATED OUTCOME MEASURES IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANAEMIA
    Kassianides, Xenophon
    Bhandari, Sunil
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I383 - I384
  • [10] THE EFFICACY OF A SINGLE DOSE OF INTRAVENOUS FERRIC CARBOXYMALTOSE (FERINJECT((R))) ON ANAEMIA IN A PRE-DIALYSIS POPULATION OF CHRONIC KIDNEY DISEASE PATIENTS
    Tagboto, Senyo
    Cropper, Liz
    Turner, June
    Pugh-Clarke, Karen
    [J]. JOURNAL OF RENAL CARE, 2009, 35 (01) : 18 - 22
12345